Avammune Therapeutics
Developer of non-nucleotide small-molecule inhibitors designed for the treatment of cancer and infectious diseases. The company develops a multimodal approach that employs a combination of engineered ...
Valuation
$33M
Market implied
Share Price
N/A
Total Raised
$18.5M
Last Round
N/A